The closing price of NKGen Biotech Inc (NASDAQ: NKGN) was $0.86 for the day, up 3.22% from the previous closing price of $0.84. In other words, the price has increased by $+0.0200 from its previous closing price. On the day, 603634 shares were traded.
Ratios:
Our analysis of NKGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.27 and its Current Ratio is at 0.27.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 07 when Song Paul Y. bought 76 shares for $3.29 per share. The transaction valued at 250 led to the insider holds 171,121 shares of the business.
Song Paul Y. bought 75 shares of NKGN for $250 on Dec 06. The Chief Executive Officer now owns 171,045 shares after completing the transaction at $3.32 per share. On Dec 05, another insider, Song Paul Y., who serves as the Chief Executive Officer of the company, bought 105 shares for $3.33 each. As a result, the insider paid 350 and bolstered with 170,969 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NKGN now has a Market Capitalization of 18.87M and an Enterprise Value of 30.12M. Its current Enterprise Value per Revenue stands at 964.78 whereas that against EBITDA is -0.56.
Stock Price History:
Over the past 52 weeks, NKGN has reached a high of $12.88, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is 2.0416, while the 200-Day Moving Average is calculated to be 2.6879.
Shares Statistics:
NKGN traded an average of 79.97K shares per day over the past three months and 62.84k shares per day over the past ten days. A total of 21.45M shares are outstanding, with a floating share count of 8.65M. Insiders hold about 60.46% of the company’s shares, while institutions hold 14.84% stake in the company. Shares short for NKGN as of Feb 15, 2024 were 311.57k with a Short Ratio of 4.14, compared to 331.01k on Jan 12, 2024.
